1887

Abstract

SUMMARY

Human peripheral blood leukocytes were treated with concanavalin A (Con A) to produce interferon γ (HuIFN-γ). On gel filtration this interferon eluted as a protein with a molecular weight of 45000. In addition to this, the culture supernatant contained an interferon-like protein of apparent molecular weight 22000 (22K factor). The antiviral activity of this protein was neutralizable by a highly specific antibody to HuIFN-β. Yet, the 22K factor differed from classical HuIFN-β in several characteristics: lack of activity on certain homologous and heterologous cells which are sensitive to HuIFN-β; lack of affinity for zinc-chelate and Con A-Sepharose columns; failure to bind to an anti-HuIFN-β antibody column. Moreover, a specific antiserum raised against the 22K factor did not neutralize HuIFN-β. Two alternative explanations of these findings are proposed: (i) the 22K factor is an interferon whose molecular structure resembles that of the known HuIFN-β but it is not identical to it, or (ii) the 22K factor is not an interferon but a protein that can induce the production of HuIFN-β in certain lines of fibroblastoid cells.

Keyword(s): IFN (HuIFN) , inducer and lymphocytes
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-64-8-1819
1983-08-01
2024-12-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/64/8/JV0640081819.html?itemId=/content/journal/jgv/10.1099/0022-1317-64-8-1819&mimeType=html&fmt=ahah

References

  1. De Ley M., Billiau A. 1982; Responsiveness of human cells trisomic for chromosome 21 to the antiviral action of human immune interferon. Antiviral Research 2:97–102
    [Google Scholar]
  2. De Ley M., Van Damme J., Claeys H., Weening H., Heine J., Billiau A., Vermylen C., De Somer P. 1980; Interferon induced in human leukocytes by mitogens: production, partial purification and characterization. European Journal of Immunology 10:877–883
    [Google Scholar]
  3. Deley M., Van Damme J., Billiau A., De Somer P. 1981; The preparation of antibodies directed against human immune interferon. Journal of Virological Methods 3:149–153
    [Google Scholar]
  4. Epstein L. B. 1979; The comparative biology of immune and classical interferons. In Biology of the Lymphokines pp 443–514 Edited by Cohen S., Pick E., Oppenheim J. New York: Academic Press;
    [Google Scholar]
  5. Havell E. A., Berman B., Ogburn C. A., Berg K., Paucker K., Vilček J. 1975; Two antigenically distinct species of human interferon. Proceedings of the National Academy of Sciences, U. S. A 72:2185–2187
    [Google Scholar]
  6. Sehgal P. B., Sagar A. D. 1980; Heterogeneity of poly(I). poly(C)-induced human fibroblast interferon mRNA species. Nature, London 288:95–97
    [Google Scholar]
  7. Stewart W. E. H. 1979 The Interferon System p 421 Wien & New York: Springer-Verlag;
    [Google Scholar]
  8. Tavernier J., Derynck R., Fiers W. 1981; Evidence for a unique human fibroblast (IFN-β1) chromosomal gene, devoid of intervening sequences. Nucleic Acids Research 9:461–471
    [Google Scholar]
  9. Van Damme J., Billiau A. 1981; Large-scale production of human fibroblast interferon. Methods in Enzymology 78:101–119
    [Google Scholar]
  10. Van Damme J., De Ley M., Claeys H., Billiau A., Vermylen C., De Somer P. 1981; Interferon induced in human leukocytes by concanavalin A: isolation and characterization of γ- and β-type components. European Journal of Immunology 11:937–942
    [Google Scholar]
  11. Weissenberg J., Chernajovsky Y., Zeevi M., Shulman L., Soreq H., Nir U., Wallach D., Perriards M., Tiollaias P., Revel M. 1980; Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proceedings of the National Academy of Sciences, U. S. A 77:7152–7156
    [Google Scholar]
  12. Yip Y. K., Barrowclough B. S., Urban C., Vilček J. 1982; Molecular weight of human gamma interferon is similar to that of other human interferons. Science 215:411–413
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-64-8-1819
Loading
/content/journal/jgv/10.1099/0022-1317-64-8-1819
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error